Dr. Korman's clinical interest is in the diagnosis and management of patients with scleroderma and other related autoimmune connective tissue diseases. He works to provide interdisciplinary care for patients including addressing problems with skin (fibrosis and thickening), blood vessels (Raynaud's phenomenon), gastrointestinal issues (acid reflux, GI motility problems), lung disease (interstitial lung disease, pulmonary hypertension), heart, and kidney problems. He is interested in providing individualized care and is well versed in cutting-edge immunotherapeutics as well symptom-relieving modalities.
Dr. Korman's research program focuses on understanding the cells and processes which cause scarring (fibrosis) in scleroderma. He uses both experimental models of disease and patient samples to better understand the relationship between adipose (fat) cells, blood vessels and scar-forming cells (fibroblasts). The ultimate goal of this work is to better understand why patients have different disease manifestations and to provide personalized treatment approaches.
Dr Benjamin Korman, M.D. is a rheumatologist and physician-scientist with a clinical and research interest in scleroderma (systemic sclerosis, SSc). Dr Korman did his undergraduate and medical training at The Ohio State University, followed by research time at the National Institutes for Health, and internal medicine residency and rheumatology fellowship training at Northwestern University in Chicago, IL. He spent two years on the faculty at Northwestern before coming to the University of Rochester where he now serves as an Assistant Professor in the Department of Medicine, Division of Allergy, Immunology, and Rheumatology.
Bell RD, White RJ, Garcia-Hernandez ML, Wu E, Rahimi H, Marangoni RG, Slattery P, Duemmel S, Nuzzo M, Huertas N, Yee M, O'Reilly MA, Morrell C, Ritchlin CT, Schwarz EM, Korman BD. "TNF Induces Obliterative Pulmonary Vascular Disease in a Novel Model of Connective Tissue Disease Associated Pulmonary Arterial Hypertension (CTD-PAH)." Arthritis & rheumatology.. 2020 May 10; Epub 2020 May 10.
Lemay M, Korman B, Hammert W, White RJ, Lachant D. "Combination treprostinil with sympathectomy and vascular reconstruction to treat recurrent digital ulcer disease." Clinical and experimental rheumatology.. 2020 Apr 15; Epub 2020 Apr 15.
Gourh P, Safran SA, Alexander T, Boyden SE, Morgan ND, Shah AA, Mayes MD, Doumatey A, Bentley AR, Shriner D, Domsic RT, Medsger TA, Ramos PS, Silver RM, Steen VD, Varga J, Hsu V, Saketkoo LA, Schiopu E, Khanna D, Gordon JK, Kron B, Criswell LA, Gladue H, Derk CT, Bernstein EJ, Bridges SL, Shanmugam VK, Kolstad KD, Chung L, Kafaja S, Jan R, Trojanowski M, Goldberg A, Korman BD, Steinbach PJ, Chandrasekharappa SC, Mullikin JC, Adeyemo A, Rotimi C, Wigley FM, Kastner DL, Boin F, Remmers EF. "and autoantibodies define scleroderma subtypes and risk in African and European Americans and suggest a role for molecular mimicry." Proceedings of the National Academy of Sciences of the United States of America.. 2019 Dec 23; Epub 2019 Dec 23.
VIEW ALL PUBLICATIONS